On Dcember 30, 2021, the Draft Standards for Pharmaceutical Excipients of Soybean Oil (for Injection) formulated by the National Engineering Research Center for Chinese Pharmaceutical Manufacturing Technology and New Drug Development of Guangzhou Hanfang Pharmaceutical Co., Ltd. (“Engineering Center”) was publicized on the official website of Chinese Pharmacopoeia Commission.
       The Engineering Center has more than 10 years of experience in the R&D of pharmaceutical raw materials and excipients, including medicinal soybean oil, soybean oil for injection, etc. In the long-term research and test, it has continuously improved the technical level and product quality of products, and enhanced the quality control on impurities in soybean oil raw materials and the control over production process, so as to ensure the stability and safety of soybean oil.